Literature DB >> 8746696

Prospective characterization of the clinicopathologic and immunologic features of an immunodeficiency syndrome affecting juvenile llamas.

J M Hutchison1, F B Garry, E B Belknap, D M Getzy, L W Johnson, R P Ellis, S L Quackenbush, J Rovnak, E A Hoover, G L Cockerell.   

Abstract

The clinicopathologic and immunologic features of 15 llamas affected with juvenile llama immunodeficiency syndrome (JLIDS) are described. Healthy adult (n = 10) and juvenile (n = 10) llamas served as controls. JLIDS llamas were characterized by wasting, and clinically apparent, repeated infections were frequently observed. The median age at which a health problem was first perceived was 11.6 months. All 15 affected llamas died or were killed, and JLIDS was confirmed at necropsy. The median duration of illness was 3.5 months. Lymphocyte blastogenesis assays showed suppressed responses (particularly to Staphylococcus sp. Protein A) in JLIDS llamas. No evidence of retroviral infection was detected. Mild, normocytic, normochromic, non-regenerative anemia, low serum albumin concentration and low to low-normal globulin concentrations were typically found on initial clinical evaluation. Lymph node biopsies showed areas of paracortical depletion. All llamas affected with JLIDS had low serum IgG concentrations, pre-vaccination titers against Clostridium perfringens C and D toxoids of < or = 1:100, and no titer increase following vaccination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746696     DOI: 10.1016/0165-2427(95)05474-x

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Immunodeficiency syndrome in a 3-year-old llama.

Authors:  M Sivasankar
Journal:  Can Vet J       Date:  1999-04       Impact factor: 1.008

2.  Mycoplasma haemolamae infection in a 4-day-old cria: support for in utero transmission by use of a polymerase chain reaction assay.

Authors:  Frederic S Almy; Sabine M Ladd; D Phillip Sponenberg; Mark V Crisman; Joanne B Messick
Journal:  Can Vet J       Date:  2006-03       Impact factor: 1.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.